-
Interpol seized $41 mn fake drugs to be sold online
biospectrumasia
October 12, 2018
Interpol seized $41 mn fake drugs to be sold online
-
First generic of diabetes drug Actos approved
biospectrumasia
October 12, 2018
First generic of diabetes drug Actos approved
-
Bayer Appoints Lead for Pharmaceuticals Business in the Americas
americanpharmaceuticalreview
September 28, 2018
Bayer announced the appointment of Sebastian Guth as President of Pharmaceuticals, Americas Region, comprising the United States, Canada, Central and Latin America, effective December 1, 2018.
-
Arena Pharmaceuticals Reports Positive Results for Olorinab
americanpharmaceuticalreview
September 27, 2018
Arena Pharmaceuticals announced positive topline results from its Phase 2a trial of olorinab, an investigational, peripherally restricted, highly selective, full agonist of the cannabinoid receptor 2 (CB2) in development for the treatment of gastrointesti
-
JB Chemicals and Pharmaceuticals gets US FDA nod for Panoli facility
financialexpress
May 21, 2018
JB Chemicals and Pharmaceuticals said that the US health regulator has completed the inspection of its Panoli facility in Gujarat with two minor observations.
-
New molecule to improve pharmaceuticals draws inspiration from nature’s toolbox
europeanpharmaceuticalreview
May 17, 2018
New catalyst is specifically tuned to integrate fluorine atoms into a new organic product…
-
Engineers make drug microparticles a thousand times faster than ever before
europeanpharmaceuticalreview
May 15, 2018
Engineers have developed a microfluidic system where more than ten thousand of these devices run in parallel, all on a silicon-and-glass chip that can fit into a shirt pocket…
-
NeuClone Discloses Details of its Fifth Product: A Biosimilar Candidate for Prolia/XGEVA (Denosumab)
prnasia
January 09, 2018
Australian biopharmaceutical company NeuClone Pty. Ltd. today disclosed the fifth biosimilar candidate being developed in its pipeline of monoclonal antibody (mAb) products.
-
India fast emerging as inventors' hub for drugs patent
newkerala
December 26, 2017
India is fast emerging as an inventors' hub for patents for an assortment of drugs worldwide
-
Sundia MediTech Co., Ltd. Company Overview
PharmaSources.com
December 20, 2017
Sundia has continued to expand its scale, and developed the laboratory area from the original 500m2 to the present 23,000m2, with first-class research and production facilities.